Clik here to view.
Researchers pit novel version of common virus against cancer
With nearly $1 million in government funding, University of Rochester scientists are testing a new innovation in biotherapy by altering a common childhood respiratory virus, the adenovirus, to destroy...
View ArticleClik here to view.
Gene therapy eradicates pancreatic cancer in preclinical trial
HOUSTON -- A molecularly engineered therapy selectively embeds a gene in pancreatic cancer that shrinks or eradicates tumors, inhibits metastasistermterm, and prolongs survival with virtually no...
View ArticleClik here to view.
Potential new target for cancer found
DURHAM, N.C. – By bypassing a well-known gene implicated in almost one-third of all cancers and instead focusing on the protein activated by the gene, Duke University Medical Center researchers...
View ArticleClik here to view.
Avalon Pharmaceuticals Advances AVN944 into a Phase II Clinical Trial in...
Avalon Pharmaceuticals, Inc. (NASDAQ:AVRX) , today announced the initiation of a Phase II clinical trial in pancreatic cancer patients. The protocol has been activated and is now open for enrollment...
View ArticleClik here to view.
New minimally invasive sampling technique allows for earlier diagnosis of...
PHILADELPHIA – A new optical technology, coupled with routine endoscopy, may enable doctors to detect the subtle tell-tale traces of early pancreatic cancer, according to researchers at Northwestern...
View ArticleClik here to view.
Obesity and lack of exercise could enhance the risk of pancreatic cancer
PHILADELPHIA – Obesity and aversion to exercise have become hallmarks of modern society – and a new study suggests that a blood protein linked to these lifestyle factors may be an indicator for an...
View ArticleClik here to view.
New treatment combination safe for pancreatic cancer patients
CHICAGO, June 2 – Treating pancreatic cancer with a combination of chemotherapyterm, biotherapy and radiotherapy prior to surgery is safe and may be beneficial for patients, according to a...
View ArticleClik here to view.
Seattle's Swedish Cancer Institute First in U.S. to Treat Cancer Patient with...
A patient with pancreatic cancer recently became the first person in the United States to receive treatment using Elekta VMAT (Volumetric intensity Modulated Arc Therapy) at Seattle's Swedish Cancer...
View ArticleClik here to view.
Stereotactic radiotherapy slows pancreatic cancer progression for inoperable...
DETROIT – For pancreatic cancer patients unable to undergo surgery – the only known cure for this form of cancer – a highly targeted cancer radiation therapy may help slow cancer progression and...
View ArticleClik here to view.
Molecular master switch for pancreatic cancer identified, potential predictor...
PHILADELPHIA – A recently described master regulator protein may explain the development of aberrant cell growth in the pancreas spurred by inflammationA team from the Perelman School of Medicine at...
View Article
